scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1030363254 |
P356 | DOI | 10.1186/S13014-015-0436-2 |
P932 | PMC publication ID | 4496940 |
P698 | PubMed publication ID | 26159409 |
P5875 | ResearchGate publication ID | 279989362 |
P50 | author | Suvi Sirkku Tuohinen | Q57613905 |
P2093 | author name string | Pirkko-Liisa Kellokumpu-Lehtinen | |
Pekka Raatikainen | |||
Vesa Virtanen | |||
Eeva Boman | |||
Tanja Skyttä | |||
P2860 | cites work | Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies | Q27000263 |
Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment | Q31123683 | ||
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy | Q33183838 | ||
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials | Q34054354 | ||
Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer | Q34118122 | ||
Enhanced sensitivity to low dose irradiation of ApoE-/- mice mediated by early pro-inflammatory profile and delayed activation of the TGFβ1 cascade involved in fibrogenesis | Q34602939 | ||
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes | Q35925266 | ||
Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer | Q36032531 | ||
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer | Q36637777 | ||
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients | Q36988282 | ||
European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies | Q37200104 | ||
Heart failure with preserved ejection fraction in the elderly: scope of the problem | Q37633991 | ||
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography | Q38133653 | ||
Outcomes in patients with heart failure with preserved ejection fraction | Q38224336 | ||
Heart failure with preserved ejection fraction: Defining the function of ROS and NO. | Q38482322 | ||
Risk of ischemic heart disease in women after radiotherapy for breast cancer | Q43615460 | ||
Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines | Q43840614 | ||
Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. | Q46125897 | ||
Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats | Q46754121 | ||
Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers? | Q48229693 | ||
Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer | Q48703366 | ||
High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide | Q48917080 | ||
Serum levels of high-sensitivity troponin T: a novel marker for left ventricular remodeling and performance in hypertensive subjects. | Q51318301 | ||
N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. | Q53221109 | ||
Subclinical cardiac dysfunction detected by strain imaging during breast irradiation with persistent changes 6 weeks after treatment. | Q53508184 | ||
The incidence and functional consequences of RT-associated cardiac perfusion defects. | Q53573289 | ||
Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. | Q53657880 | ||
Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. | Q53855288 | ||
Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? | Q54596767 | ||
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. | Q54702884 | ||
Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction | Q57315206 | ||
Serum cardiac troponin T levels during treatment of early-stage breast cancer | Q71832948 | ||
Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study | Q71875608 | ||
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats | Q80458516 | ||
Long-term cardiovascular mortality after radiotherapy for breast cancer | Q83251863 | ||
Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods | Q83964012 | ||
Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population | Q84977707 | ||
Mechanisms and dose-response relationships for radiation-induced cardiovascular disease | Q85249480 | ||
Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy | Q85424948 | ||
Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk | Q87264249 | ||
Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure | Q87607038 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 141 | |
P577 | publication date | 2015-07-10 | |
P1433 | published in | Radiation Oncology | Q2313370 |
P1476 | title | Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy | |
P478 | volume | 10 |
Q92073283 | Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy |
Q92120577 | BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: a meta-analysis |
Q88868148 | Biomarker Discovery in Cardio-Oncology |
Q61454620 | Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity |
Q45040846 | Biomarkers of cardiac injury in patients undergoing thoracic radiation therapy |
Q98154746 | Biomarkers of radiation-induced vascular injury |
Q30251498 | Cancer drug related cardiotoxicity during breast cancer treatment |
Q50045986 | Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. |
Q57811270 | Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer |
Q90478154 | Detection of radiation induced cardiotoxicity: Role of echocardiography and biomarkers |
Q93175092 | Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma |
Q36774819 | Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study. |
Q92440937 | Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer |
Q39029699 | Effects of ionizing radiation on the heart |
Q47757777 | Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer |
Q57477384 | Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention |
Q47772072 | High sensitivity troponins in contemporary cardiology practice: are we turning a corner? |
Q88683757 | How to prevent and manage radiation-induced coronary artery disease |
Q50894688 | Infundibular pulmonary stenosis after radiotherapy for breast cancer. |
Q28071302 | Novel concepts in radiation-induced cardiovascular disease. |
Q94547024 | Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer |
Q89521140 | Radiation and cardiovascular disease |
Q39185680 | Radiation-Induced Cardiovascular Disease |
Q45072741 | Radiation-Induced Cardiovascular Disease: A Clinical Perspective |
Q90047697 | Relationship Between Changes in Myocardial F-18 Fluorodeoxyglucose Uptake and Radiation Dose After Adjuvant Three-Dimensional Conformal Radiotherapy in Patients with Breast Cancer |
Q55429574 | Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment. |
Search more.